US Patent Issued to EVOPOINT BIOSCIENCES on Sept. 22 for "Antibody, antibody-drug conjugate thereof and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,009, issued on Sept. 22, was assigned to EVOPOINT BIOSCIENCES Co. LTD. (China).

"Antibody, antibody-drug conjugate thereof and use thereof" was invented by Yonghan Hu (Jiangsu, China), Linfeng Xu (Jiangsu, China), Zhenwei Wu (Jiangsu, China), Ka Ruan (Jiangsu, China) and Wengui Wang (Jiangsu, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antibody and an antibody-drug conjugate, which relate to an antibody and an antibody-drug conjugate (ADC) targeting Claudin 18.2 (CLDN18.2), as well as compositions containing the antibody and ADC molecules, and a therapeutic application thereof."

The patent was filed on Sept. 27, 2022, under Application...